Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and …PR.com (press release)… covers a platform of versatile polyethylene glycol-based foam formulations, which can carry a variety of dermatological and gynecologica…
FDA Approves Novartis's Afinitor Tablets To Treat Patients With Kidney TumorsNASDAQ(RTTNews.com) – Novartis Pharmaceuticals Corp., an affiliate of Novartis AG (NVS), announced today that the US Food and Drug Administration approved Afinitor (everol…
Cape GazetteWalk Aims to Stop Chronic Kidney DiseasePatch.comOn Sunday, hundreds will take part in the Northern New Jersey Kidney Walk to help raise awareness and funds to support those with chronic kidney disease and the millions more who are at risk …
FDA approves Novartis Afinitor to treat kidney tumorsPharmaceutical Business ReviewThe US Food and Drug Administration (FDA) has approved Novartis Afinitor (everolimus) to treat patients with non-cancerous kidney tumors associated with tuberous scleros…
Organ banks to be set up in Bangalore hospitalsDaily News & AnalysisAccording to the Transplantation of Human Organ Act 1994, a living donor can donate only a kidney, portion of pancreas or part of the liver whereas a cadaver organ donor can donate all…
A policy instituted in 2005 has reduced racial disparities in kidney transplantation among children, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
Share 35 policy reduces racial disparities in kidney transplantation among …News-Medical.netA policy instituted in 2005 has reduced racial disparities in kidney transplantation among children, according to a study appearing in an upcoming issue of th…
THURSDAY, April 26 (HealthDay News) — Racial disparities in kidney transplants for U.S. children have fallen since a new policy was introduced in 2005 by the United Network for Organ Sharing, researchers say.
Three Georgia boys die unexpectedly after dental procedureWGCL Atlanta"You get swelling of the brain and then you get either brain damage or brain death." Dr. Baxter says our mouths have more bacteria than any other part of our body, and that…
Gilead Sciences Management Discusses Q1 2012 Results – Earnings Call TranscriptSeeking AlphaAs a final R&D highlight, 3 Phase III studies will be initiated in patients with relapsed or refractory chronic lymphocytic leukemia, or CLL, which is 1101 …